Treace Medical Concepts Outperforms Expectations in Third Quarter

Treace Medical Concepts reported 3Q21 orthopedic sales of $21.6 million, +51.5% vs. 3Q20. Unlike many other orthopedic companies, Treace's sales accelerated from the second to third quarters, growing +4.7% sequentially despite COVID and staffing headwinds. The company beat most analysts' expectations, with sales growth driven by a +41%...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us